for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
−Removed: common stock is quoted on the OTCQB under the symbol “RAKR”.
−Removed: The high and low bid prices of our common stock for the periods
−Removed: indicated below are as follows:
+Added: common stock is quoted on the OTC:
+Added: Pink under the symbol “RAKR”.
+Added: The high and low bid prices of our common stock for the
+Added: periods indicated below are as follows:
Quarter Ended
8 unchanged sentences
yahoo!finance Historical Data
−Removed: reflect inter dealer prices, without retail mark up, markdown or commissions and may not represent actual transactions.
+Added: reflect interdealer prices, without retail mark up, markdown or commissions and may not represent actual transactions.
number of holders of record of RAKR common stock at the time of filing was approximately 4,153.
Many of our shares of common stock are
−Removed: held by brokers and other institutions on behalf of stockholders, so we are unable to estimate the number stockholders represented by
−Removed: the record holders.
+Added: held by brokers and other institutions on behalf of stockholders, so we are unable to estimate the number of stockholders represented
+Added: by the record holders.
transfer agent for RAKR common stock is Pacific Stock Transfer, 6725 Via Austi Pkwy, Suite 300 Las Vegas, NV 89119.
10 unchanged sentences
All expire December 31, 2025.
+Added: As of January
+Added: 8, 2024, these warrants have been repriced at $0.001389.
January 22, 2020, the Company entered into a three-year consulting agreement with a third party for consulting and business development
−Removed: The contract included warrants of which 25,000,000 remain in effect exercisable at $0.20 and expire January 21, 2023.
+Added: The contract included warrants of which 25,000,000 remain in effect exercisable at $0.20 and expired January 21, 2023.
October 1, 2020, the Company entered into a consulting agreement with an Advisor which granted warrants in full compensation for services.
−Removed: It included 13,500,000 warrants at an exercise price of $0.30 expiring October 1, 2023 and of 15,000,000 warrants at an exercise price
−Removed: of $0.15 expiring October 1, 2025.
+Added: It included 13,500,000 warrants at an exercise price of $0.30 now expired as of October 1, 2023.
+Added: A further 15,000,000 warrants were issued
+Added: at an exercise price of $0.15 expiring October 1, 2025.
April 1, 2021, the Company granted 4,100,000 options as part of an amendment to an Executive Consultant’s contract;
1 unchanged sentence
vest per month commencing April 1, 2021 with a term of 5 years and exercisable at a price of $0.10 per Share.
+Added: As of January 8, 2024,
+Added: these options have been repriced at $0.001389.
December 21, 2021, the Company granted 500,000 options to each of the two new Directors;
3 unchanged sentences
with a 20% discount to market based on a 30-day VWAP if it falls below $0.10, not to go below $0.07.
+Added: These options are fully vested as
+Added: of December 31, 2023.
+Added: As of January 8, 2024, these options have been repriced at $0.001389.
July 1, 2022, the Company granted 1,500,000 options to new VP Sales with an exercise price of $0.10 and a 5-year term with 640,000 vesting
2 unchanged sentences
an exercise price of $0.10 and a 5-year term with 500,000 vesting immediately and the balance vesting equally over one year.
+Added: As of January
+Added: 8, 2024, these options have been repriced at $0.001389.
Financial Data
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.